People under 50 in the UK will begin to be offered Moderna’s Covid-19 vaccine within three weeks, according to a report in the Mail on Sunday.
More than 500,000 new doses of the US vaccine will be used to expanded the programme to people in lower age cohorts in mid-April, the paper says.
Doctors are expected to administer the first doses of the new vaccine, which will join Pfizer and AstraZeneca in the UK’s vaccine stocks, within three weeks.